Evidence map›Paper›PMID 22378288›Full record

ArticleEuropean journal of human genetics : EJHG2012

DNA replication is altered in Immunodeficiency Centromeric instability Facial anomalies (ICF) cells carrying DNMT3B mutations.

Erica Lana, André Mégarbané, Hélène Tourrière, Pierre Sarda, Gérard Lefranc, Mireille Claustres, Albertina De Sario

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Epigenetic Alterations in Inborn Errors of Immunity.Journal of clinical medicine · 2022
    Review
  4. Review
  5. OverexpressingOncotarget · 2018
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Erica LanaINSERM U827, av. du Doyen Gaston Giraud, Montpellier, France.
André Mégarbané
Hélène Tourrière
Pierre Sarda
Gérard Lefranc
Mireille Claustres
Albertina De Sario
Inserm · FRUniversité de Montpellier · FRCentre National de la Recherche Scientifique · FRSaint Joseph's University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ICF syndrome is a rare autosomal recessive disorder that is characterized by Immunodeficiency, Centromeric instability, and Facial anomalies. In all, 60% of ICF patients have mutations in the DNMT3B (DNA methyltransferase 3B) gene, encoding a de novo DNA methyltransferase. In ICF cells, constitutive heterochromatin is hypomethylated and decondensed, metaphase chromosomes undergo rearrangements (mainly involving juxtacentromeric regions), and more than 700 genes are aberrantly expressed. This work shows that DNA replication is also altered in ICF cells: (i) heterochromatic genes replicate earlier in the S-phase; (ii) global replication fork speed is higher; and (iii) S-phase is shorter. These replication defects may result from chromatin changes that modify DNA accessibility to the replication machinery and/or from changes in the expression level of genes involved in DNA replication. This work highlights the interest of using ICF cells as a model to investigate how DNA methylation regulates DNA replication in humans.

Indexed as

Mutation, MissenseCell LineDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BFaceGene ExpressionHeterochromatinHumansImmunologic Deficiency SyndromesPrimary Immunodeficiency DiseasesS PhaseDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BHeterochromatin

Identifiers

PMID22378288
PMCPMC3449075
OpenAlexW1997058180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.